InfertilityGeneticsFertilityIVF and assisted reproductionProcedure
What this study is
This research is a prospective study in which the purpose is to investigate the clinical outcomes following the transfer of a mosaic embryo (presence of both chromosomally normal and abnormal cells) that has been screened for preimplantation genetic testing (PGT).
What's being tested
- Transfer of mosaic embryo
Intervention · PROCEDURE
Subjects will transfer a mosaic embryo transferred to their uterus
Study details
- Sponsor
- Colorado Center for Reproductive Medicine
- Conditions
- Infertility
- Enrolling
- 250 people
- Starts
- 2020-10-15
- Est. completion
- 2026-12-15
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 45 YearsSex FEMALEHealthy volunteers AcceptedYou may qualify if
- Women age 18-45 Infertile women who have completed an IVF cycle with PGT at the Colorado Center for Reproductive Medicine (CCRM) that have a mosaic embryo
- Patients can be of any race, culture, sexual orientation or ethnicity
- Patients that are willing to transfer a single embryo
You can't join if
- Patients that do not meet the clinical requirements for an embryo transfer per clinic standards.
- Patients that desire more than a single embryo transfer.
- Patients that are using a gestational carrier.
- Embryonic mosaic PGT results that include chromosome errors 13, 18, 21
- Patients that did not complete their IVF with PGT cycle at the Colorado Center for Reproductive Medicine.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openColorado Center for Reproductive Medicine
Lone Tree, Colorado, United States
- Rachel Makloski, RN · ContactTriggerStudy@colocrm.com
Recruiting
Study team
Sponsor
Colorado Center for Reproductive Medicine
Study ID Mosaic
Principal investigator
Mandy Katz-Jaffe, PhD
Fertility Genetics
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.